Ralliant Corporation (NYSE:RAL) Given Consensus Rating of “Moderate Buy” by Brokerages

Ralliant Corporation (NYSE:RAL) has been given a consensus rating of “Moderate Buy” by the ten brokerages that are presently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $58.00.

A number of equities analysts have commented on RAL shares. Barclays lifted their target price on shares of Ralliant from $59.00 to $60.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 7th. Citigroup raised shares of Ralliant from a “neutral” rating to a “buy” rating and lifted their price target for the company from $53.00 to $61.00 in a research report on Monday, December 8th. Truist Financial began coverage on Ralliant in a research report on Friday, December 12th. They issued a “buy” rating and a $62.00 price objective for the company. Oppenheimer lifted their target price on Ralliant from $55.00 to $60.00 and gave the company an “outperform” rating in a research report on Monday, December 15th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Ralliant in a report on Monday, December 29th.

Ralliant Stock Performance

NYSE RAL opened at $52.86 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.03 and a current ratio of 1.49. The stock’s fifty day moving average is $51.52 and its two-hundred day moving average is $46.69. The firm has a market capitalization of $5.96 billion and a P/E ratio of 41.62. Ralliant has a fifty-two week low of $40.70 and a fifty-two week high of $55.25.

Ralliant (NYSE:RAL) last issued its earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.58 by $0.02. The company had revenue of $529.10 million during the quarter, compared to analyst estimates of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be given a dividend of $0.05 per share. The ex-dividend date is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. Ralliant’s dividend payout ratio (DPR) is currently 15.75%.

Hedge Funds Weigh In On Ralliant

Several large investors have recently made changes to their positions in the stock. GAMMA Investing LLC purchased a new position in shares of Ralliant during the 2nd quarter worth approximately $56,000. Public Employees Retirement System of Ohio purchased a new position in shares of Ralliant during the second quarter worth $1,799,000. V Square Quantitative Management LLC acquired a new stake in shares of Ralliant in the second quarter valued at $131,000. Truist Financial Corp purchased a new stake in shares of Ralliant in the 2nd quarter valued at $1,409,000. Finally, Bartlett & CO. Wealth Management LLC acquired a new position in Ralliant during the 2nd quarter worth about $74,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.